跳至主要内容
临床试验/ISRCTN13358395
ISRCTN13358395已完成不适用

Protection against chemotherapy induced damage in the digestive tract in childhood cancer patients

Danone Research B.V. (The Netherlands)0 个研究点目标入组 30 人开始时间: 2006年1月27日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children with acute non-lymphocytic leukaemia (ANLL), myelodysplastic syndromes (MDS), B-cell non-hodgkin's lymphoma (B-NHL), infant acute lymphoblastic leukaemia (ALL) who will receive two or more similar courses of chemotherapy
  • 2. Children diagnosed with other malignancies who receive more than two similar courses of chemotherapy and develop mucosal barrier injury during one of the first courses
  • 3. Aged 0 - 18 years
  • 4. Informed consent

排除标准

  • 1. Clinical signs of inflammatory bowel disease, coeliac disease or cow's milk protein allergy
  • 2. Radiotherapy of the abdomen less than 6 months before TGF-beta administration

研究者

发起方
Danone Research B.V. (The Netherlands)

相似试验

Protection against chemotherapy induced damage in... | 临床试验